Drug response assessment trials for inhaled hypertonic saline in patients with bronchiectasis: Analysis of data from the CLEAR trial - Amsterdam 2025

Clinical perspectives on bronchiectasis severity and comorbidities

Chair(s): Georgia Trakada, Charles Haworth

Session type: Poster session

Drug response assessment trials for inhaled hypertonic saline in patients with bronchiectasis: Analysis of data from the CLEAR trial

Rebecca H. McLeese

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Rhinosinusitis with nasal polyposis is a clinical predictor of type 2 inflammation in bronchiectasis: an EMBARC registry analysis

Michal Shteinberg

Poster

Abstract

Analysis of the phenotypes of cystic nonfibrosis bronchiectasis and their impact on clinical practice

Carlos Sanchez Villar

Poster

Abstract

Bronchiectasis severity index: Prognostic performance in predicting mortality

Haifa Zaibi

Poster

Abstract

Is multimorbidity a clinical predictor of poor outcomes in bronchiectasis?:A BronchUK registry analysis

Tony De Soyza

Poster

Abstract

Non-cystic fibrosis bronchiectasis (NCFB): correlation between symptoms, pulmonary function, and exacerbations in outpatients during one year of follow-up

Martina Meocci

Poster

Abstract

Predictors of Cardiovascular events in patients with bronchiectasis: A single centre EMBARC analysis

Jaa Ming (ben) New

Poster

Abstract

Anxiety, depression and bronchiectasis severity index scores in patients with non-cystic fibrosis bronchiectasis

Matthew Brunige

Poster

Abstract

Morbidity in patients with NCFBE and exacerbations in the THIN UK database

Michael Loebinger

Poster

Abstract

Morbidity in patients with NCFBE and exacerbations in the THIN France database

Pierre-régis Burgel

Poster

Abstract

Assessment of non-cystic fibrosis bronchiectasis severity: The FACED Score vs the Bronchiectasis Severity Index

Soumaya Debiche

Poster

Abstract

Exploring the overlapping burden of alpha-1 antitrypsin deficiency and bronchiectasis: insights from the US BRR

Radmila Choate

Poster

Abstract

Do FACED and BSI perform well in predicting long-term oxygen therapy in patients with bronchiectasis?

Haifa Zaibi

Poster

Abstract

Bronchiectasis severity scores (FACED and BSI) and systemic inflammation: is there any correlation?

Haifa Zaibi

Poster

Abstract

Prognostic assessment in bronchiectasis: the impact of comorbidities using the Charlson index

Ricardo G Figueiredo

Poster

Abstract

Relationship between inflammation and heart rate recovery after exercise in people with bronchiectasis

Juan Antonio Sáez-pérez

Poster

Abstract

Bronchiectasis and immunosuppression: a single-center analysis.

Lorenzo Arlando

Poster

Abstract

Risk factors for hemoptysis in non-cystic fibrosis bronchiectasis: the BEE case-control study

Maria Fulvia Di Grado

Poster

Abstract

Clinical significance of eosinophilic bronchiectasis in a multi-ethnic Asian cohort

Chloe Lim

Poster

Abstract

Drug response assessment trials for inhaled hypertonic saline in patients with bronchiectasis: Analysis of data from the CLEAR trial

Rebecca H. Mcleese

Poster

Abstract

Late Breaking Abstract - Lipid nanoparticle-mediated delivery of miRNA-302 mimics for enhancing host recovery from pneumonia caused by Klebsiella pneumoniae

Yuzhen Xu

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}